Alerts will be sent to your verified email
Verify EmailZOTA
Zota Health Care
|
Orchid Pharma
|
Gufic Biosciences
|
|
---|---|---|---|
Operational Metrics
|
|||
Retail
|
|||
Number of Stores - Franchises
|
562.0 . | n/a | n/a |
Number of Stores
|
604.0 . | n/a | n/a |
Number of Stores - Company Owned
|
42.0 . | n/a | n/a |
Telecom Sector
|
|||
Average Revenue Per User (ARPU)
|
254.0 Rs | n/a | n/a |
Pharmaceutical Sector
|
|||
R&D as a % of Total Sales
|
0.09 % | n/a | 0.83 % |
Financials
|
|||
5 yr Average ROE
|
-1.91 % | -4.13 % | 25.05 % |
5yr average Equity Multiplier
|
1.71 | 1.73 | 2.22 |
5yr Average Asset Turnover Ratio
|
0.99 | 0.45 | 1.05 |
5yr Avg Net Profit Margin
|
-0.52 % | -7.02 % | 10.9 % |
Price to Book
|
17.22 | 3.09 | 6.06 |
P/E
|
0.0 | 46.01 | 58.83 |
5yr Avg Cash Conversion Cycle
|
38.95 Days | 49.11 Days | 26.94 Days |
Inventory Days
|
94.16 Days | 112.59 Days | 66.86 Days |
Days Receivable
|
55.69 Days | 91.49 Days | 128.09 Days |
Days Payable
|
89.31 Days | 201.52 Days | 163.91 Days |
5yr Average Interest Coverage Ratio
|
18.17 | -0.51 | 13.1 |
5yr Avg ROCE
|
1.25 % | 0.51 % | 27.25 % |
5yr Avg Operating Profit Margin
|
5.05 % | 10.69 % | 18.45 % |
5 yr average Debt to Equity
|
0.03 | 0.49 | 0.51 |
5yr CAGR Net Profit
|
n/a | n/a | 14.26 % |
5yr Average Return on Assets
|
-0.16 % | -1.77 % | 11.52 % |
Shareholdings
|
|||
Promoter Holding
|
57.42 % | 69.84 % | 72.52 % |
Share Pledged by Promoters
|
0.26 % | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-10.7 % | -20.12 % | -2.48 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 16.13 % | 2.35 % |
Zota Health Care
|
Orchid Pharma
|
Gufic Biosciences
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|